PART I Overview and Recent Developments We are a holding company incorporated in the State of Nevada. We operate through Advanced Biomed Taiwan and Advanced Biomed HK. Advanced Biomed Taiwan is responsible for the main operation and the design and development of the companys primary technologies and products. Since our establishment in 2014, we have been focusing on the integration of multiple interdisciplinary technologies and established our own microfluidic technology platform. Utilizing the ...
Q2 FY2026 — expected 2026-09-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-08 | 2025-06-30 | 0001213900-25-097465 | EDGAR | 93K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-13 | 2025-12-31 | 0001213900-26-016458 | EDGAR | 29K words |
| 2025-11-19 | 2025-09-30 | 0001213900-25-112602 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001213900-25-044148 | EDGAR | — |
| 2025-04-15 | 2024-12-31 | 0001213900-25-032066 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-03 | 0001213900-26-040030 | EDGAR | 3K words |
| 2026-03-30 | 0001213900-26-036424 | EDGAR | — |
| 2026-03-16 | 0001213900-26-028330 | EDGAR | — |
| 2026-02-26 | 0001213900-26-020807 | EDGAR | — |
| 2026-02-02 | 0001213900-26-010809 | EDGAR | — |
| 2026-01-27 | 0001213900-26-008254 | EDGAR | — |
| 2026-01-21 | 0001213900-26-006281 | EDGAR | — |
| 2025-12-30 | 0001213900-25-126584 | EDGAR | — |
| 2025-09-19 | 0001213900-25-089566 | EDGAR | — |
| 2025-07-24 | 0001213900-25-067328 | EDGAR | — |
37 total filings indexed. 22 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001941029 |
| Ticker | ADVB |
| Exchange | Nasdaq |
| SIC | 8071: Services-Medical Laboratories |
| Incorporated | NV |
| Website | http://www.advanbiomed.com |
| Listed | 2025-03-06 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report